Fineotex Chemical Ltd
Incorporated in 1979, Fineotex Chemicals Ltd is engaged in the business of manufacturing auxiliaries and specialty chemicals for textiles, construction, water treatment, fertilizer, leather, and paint industries[1]
- Market Cap ₹ 3,655 Cr.
- Current Price ₹ 327
- High / Low ₹ 459 / 304
- Stock P/E 29.7
- Book Value ₹ 61.7
- Dividend Yield 0.48 %
- ROCE 38.7 %
- ROE 30.1 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 39.8% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 28.0%
Cons
- Promoter holding has decreased over last quarter: -1.58%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of BSE Allcap BSE Commodities Nifty Microcap 250 Nifty Total Market BSE SmallCap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
96 | 87 | 102 | 110 | 127 | 141 | 182 | 196 | 219 | 368 | 517 | 569 | 579 | |
86 | 77 | 85 | 82 | 98 | 111 | 148 | 162 | 178 | 297 | 404 | 421 | 429 | |
Operating Profit | 10 | 9 | 16 | 28 | 29 | 30 | 34 | 35 | 41 | 71 | 113 | 148 | 150 |
OPM % | 11% | 11% | 16% | 26% | 23% | 21% | 19% | 18% | 19% | 19% | 22% | 26% | 26% |
2 | 3 | 5 | 2 | 10 | 5 | 1 | -11 | 17 | 6 | 7 | 17 | 21 | |
Interest | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Depreciation | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 6 | 8 |
Profit before tax | 11 | 11 | 20 | 29 | 38 | 34 | 34 | 22 | 56 | 73 | 115 | 158 | 162 |
Tax % | 27% | 30% | 28% | 31% | 24% | 29% | 28% | 35% | 20% | 22% | 22% | 23% | |
8 | 8 | 15 | 20 | 29 | 24 | 24 | 14 | 45 | 57 | 90 | 121 | 125 | |
EPS in Rs | 0.63 | 0.58 | 1.15 | 1.56 | 2.32 | 2.04 | 2.02 | 1.18 | 3.85 | 4.98 | 7.97 | 10.82 | 11.09 |
Dividend Payout % | 8% | 9% | 9% | 13% | 4% | 10% | 5% | 4% | 8% | 8% | 10% | 15% |
Compounded Sales Growth | |
---|---|
10 Years: | 21% |
5 Years: | 26% |
3 Years: | 38% |
TTM: | 10% |
Compounded Profit Growth | |
---|---|
10 Years: | 35% |
5 Years: | 40% |
3 Years: | 41% |
TTM: | 18% |
Stock Price CAGR | |
---|---|
10 Years: | 32% |
5 Years: | 65% |
3 Years: | 43% |
1 Year: | 5% |
Return on Equity | |
---|---|
10 Years: | 23% |
5 Years: | 25% |
3 Years: | 28% |
Last Year: | 30% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 11 | 11 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 23 |
Reserves | 47 | 54 | 54 | 69 | 90 | 113 | 137 | 147 | 187 | 240 | 327 | 425 | 666 |
6 | 4 | 2 | 3 | 1 | 5 | 2 | 3 | 3 | 2 | 7 | 5 | 0 | |
17 | 19 | 23 | 20 | 26 | 21 | 34 | 35 | 54 | 75 | 67 | 96 | 76 | |
Total Liabilities | 82 | 88 | 101 | 114 | 140 | 161 | 195 | 208 | 267 | 339 | 423 | 548 | 766 |
12 | 14 | 18 | 19 | 27 | 29 | 36 | 41 | 59 | 84 | 99 | 141 | 178 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 5 | 0 | 0 | 0 | 9 |
Investments | 21 | 16 | 29 | 39 | 47 | 55 | 48 | 52 | 32 | 17 | 89 | 147 | 286 |
49 | 58 | 54 | 56 | 66 | 77 | 110 | 114 | 171 | 238 | 234 | 260 | 293 | |
Total Assets | 82 | 88 | 101 | 114 | 140 | 161 | 195 | 208 | 267 | 339 | 423 | 548 | 766 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 14 | 14 | 19 | 6 | 12 | 28 | 9 | 13 | 107 | 97 | ||
12 | -14 | -13 | -14 | -6 | 5 | -19 | -7 | 1 | -99 | -47 | ||
-4 | -3 | -1 | -6 | -4 | -3 | -4 | -4 | -6 | -6 | -24 | ||
Net Cash Flow | 9 | -3 | -1 | -1 | -3 | 14 | 6 | -2 | 8 | 1 | 26 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 64 | 92 | 80 | 84 | 84 | 72 | 98 | 100 | 138 | 110 | 72 | 89 |
Inventory Days | 59 | 68 | 56 | 66 | 70 | 97 | 84 | 66 | 79 | 98 | 53 | 55 |
Days Payable | 68 | 81 | 75 | 75 | 82 | 50 | 70 | 73 | 101 | 96 | 53 | 79 |
Cash Conversion Cycle | 55 | 79 | 60 | 75 | 72 | 119 | 112 | 93 | 116 | 111 | 72 | 64 |
Working Capital Days | 48 | 80 | 61 | 83 | 76 | 125 | 122 | 112 | 142 | 126 | 76 | 79 |
ROCE % | 17% | 15% | 21% | 31% | 35% | 26% | 22% | 20% | 28% | 30% | 36% | 39% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
15 Nov - Audio recording of Q2 FY2024-2025 investor call available.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Nov - Newspaper Advertisement for Unaudited Financial Results for quarter ended September 30, 2024
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
14 Nov - Monitoring Agency Report for Q2 2024 submitted.
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
14 Nov - Monitoring Agency Report for Q3 2024 issued.
-
Statement Of Deviation And Variation For The Quarter Ended September 30, 2024
14 Nov - Statement confirming no deviation in fund utilization.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
Nov 2024TranscriptNotesPPT
-
Aug 2024Transcript PPT REC
-
Aug 2024TranscriptNotesPPT
-
Jun 2024Transcript PPT
-
May 2024TranscriptNotesPPT
-
Mar 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT REC
-
Nov 2023TranscriptNotesPPT
-
Nov 2023TranscriptNotesPPT
-
Nov 2023TranscriptNotesPPT
-
Aug 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT
-
Jun 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Jan 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jul 2022TranscriptNotesPPT
-
May 2022Transcript PPT
-
Apr 2022TranscriptNotesPPT
-
Jan 2022Transcript PPT
-
Jan 2022TranscriptNotesPPT
-
Nov 2021Transcript PPT
-
Nov 2021TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021Transcript PPT
-
Jul 2021TranscriptNotesPPT
-
May 2021Transcript PPT
-
Apr 2021TranscriptNotesPPT
-
Feb 2021Transcript PPT
-
Jan 2021TranscriptNotesPPT
-
Jan 2021TranscriptNotesPPT
-
Nov 2020TranscriptNotesPPT
-
Nov 2020TranscriptNotesPPT
-
Nov 2020TranscriptNotesPPT
-
Sep 2020TranscriptNotesPPT
-
Jul 2020TranscriptNotesPPT
-
Feb 2020TranscriptNotesPPT
-
Feb 2020TranscriptNotesPPT
-
Nov 2019TranscriptNotesPPT
-
Nov 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
May 2019TranscriptNotesPPT
-
May 2019Transcript PPT
-
Feb 2019Transcript PPT
-
Nov 2018TranscriptNotesPPT
-
Nov 2018TranscriptNotesPPT
-
Aug 2018Transcript PPT
-
Aug 2018TranscriptNotesPPT
-
Jun 2018Transcript PPT
-
Jun 2018TranscriptNotesPPT
-
Jun 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Dec 2017TranscriptNotesPPT
-
Dec 2017TranscriptNotesPPT
-
Sep 2017TranscriptNotesPPT
-
Sep 2017TranscriptNotesPPT
-
May 2017TranscriptNotesPPT
-
Mar 2017Transcript PPT
-
Feb 2017TranscriptNotesPPT
-
Nov 2016Transcript PPT
-
Nov 2016TranscriptNotesPPT
-
Aug 2016Transcript PPT
-
Aug 2016TranscriptNotesPPT
-
May 2016Transcript PPT
-
Mar 2016TranscriptNotesPPT
-
Mar 2016TranscriptNotesPPT
-
Feb 2016TranscriptNotesPPT
-
Nov 2015TranscriptNotesPPT
-
Aug 2015TranscriptNotesPPT
Business Segments[1]
Textile Chemical segment: Specialty chemicals producer with a focus on textiles
chemicals. Biotex Malaysia spearheads the R&D solutions, application research and product development.
Cleaning and Hygiene segment: Products such as floor cleaners, hand-washes, sanitizers, dishwashers, and toilet bowl cleaners are manufactured. The company offers customised solutions.